August 10, 2020 by Deborah Weinswig
Coresight Research, Deborah Weinswig
August 10, 2020, Opinion

As nonessential stores have reopened, there have been some positive signs of consumer demand in physical formats. Despite this, Coresight Research is also seeing sustained demand for e-commerce in core drug store categories, and we expect digital demand to remain elevated over the coming months. Recent uptick in online shopping Coresight Research’s weekly survey of
April 28, 2020 by Deborah Weinswig
Coresight Research, COVID-19, Deborah Weinswig, drug chains
April 27, 2020, Opinion

U.S. brick-and-mortar retail is in crisis. This sentiment has been expressed to varying degrees in recent years as store closures and bankruptcies have piled up, but the current threat is much more immediate and pressing: The coronavirus outbreak has closed much of U.S. brick-and-mortar retail, and almost half the country has been told to stay
August 26, 2019 by Deborah Weinswig
2018 Farm Bill, cannabidiol (CBD), Coresight Research, Deborah Weinswig
August 26, 2019, Opinion

Cannabis is best known for its recreational and medical uses, but cannabis-derived ingredients are featuring in more and more products sold in stores and online. The legal cannabis market is burgeoning: Total worldwide cannabis spending is expected to be worth $24.4 billion in 2019 — and is forecast to reach $63.5 billion by 2024, a
August 22, 2018 by Deborah Weinswig
Amazon, Amazon PillPack merger, Coresight Research, Deborah Weinswig
Issue 08-13-2018, Opinion

NEW YORK — Amazon.com’s venture into the pharmacy market has finally been confirmed. On June 28, Amazon announced that it had entered into an agreement to buy U.S.-based online pharmacy PillPack. Amazon did not reveal details of the consideration, but CNBC reported that Amazon made an offer of $1 billion to acquire PillPack after Walmart
September 25, 2017 by Chain Drug Review
beauty care, beauty shopper, ColourPop, CVS Pharmacy, Deborah Weinswig, Fung Group, Impulse Beauty, MAC, NYX, Sephora, Target Corp., U.S. beauty retailing, Ulta Beauty, Walgreens, Walmart
2017, Business, Featured Articles, Issue 09-25-2017, Issues, Leading Headlines, News, Retail News

NEW YORK — The secret weapon in the battle for the $62 billion that U.S. customers spend on beauty care and cosmetics just might be something mass retailers had all along — steep values. While drug, discount and supermarket chains have burnished their image in beauty with illumination, upgraded products and elevated service, it turns
May 10, 2017 by Deborah Weinswig and Chain Drug Review
Deborah Weinswig, Fung Global Retail & Technology, pharmacist provider status, Pharmacy and Medically Underserved Areas Enhancement Act
Opinion

In the U.S., pharmacists are a crucial link in the health care supply chain. Beyond dispensing prescription medication, pharmacists have the academic training to conduct health and wellness screenings and to provide some preventative care as well as advice on healthy lifestyles. Empowering pharmacists by changing the laws governing their practice would enable them to
March 24, 2017 by Chain Drug Review
Alex Perez-Tenessa, beauty care sales, CVS Pharmacy, Dawn Block, Deborah Weinswig, Fung Global Retail and Technology, Jane Henderson, Jordan Rost, mass market beauty care, Mintel, Nielsen, NPD Group, Target Corp.
Featured Articles, Leading Headlines, Retail News

NEW YORK — Efforts that mass market retailers started last year to brush up their beauty departments and court new shoppers are starting to register. Mass market beauty care sales rose only 2% in 2016, according to NPD Group Inc. (lower than prestige at 6%), but several categories recorded impressive results. Skin care, for example,
July 1, 2016 by Deborah Weinswig and Chain Drug Review
Deborah Weinswig, digital health, Fung Global Retail & Technology, health technologies
Opinion

We all know the aging of the U.S. population is one of the biggest demographic changes of our era. This is presenting not only challenges to health care providers and governments but also opportunities for new technologies that deliver health services more efficiently, more effectively or faster. Here, we outline some key health tech innovations
May 13, 2016 by Chain Drug Review
2016 NACDS Total Store Expo, Daymond John, Deborah Weinswig, Kantar Retail, Li & Fung Business Intelligence, National Association of Chain Drug Stores, Nielsen, Nielsen Marketing Cloud, Shark Branding, Steve Anderson, Vision 2027
Leading Headlines, Retail News

ARLINGTON, Va. — The National Association of Chain Drug Stores has announced four companies that will participate in Vision 2027, its futuristic, interactive display at the 2016 NACDS Total Store Expo. NACDS said Friday that this year’s Vision participants include Li & Fung Business Intelligence, Kantar Retail, Nielsen and Shark Branding. The forward-looking Vision
April 19, 2016 by Deborah Weinswig and Chain Drug Review
Affordable Care Act, baby boomer, Deborah Weinswig, drug chains, Fung Global Retail & Technology, spending on health care
Opinion

It feels like “The boomers are coming! The boomers are coming!” has been a corporate rallying cry for a number of years now as a range of industries have worked to prepare for the aging of the population. But successfully targeting the baby boomer generation has proven elusive for many. A careful examination reveals that
September 14, 2015 by Jeffrey Woldt and Chain Drug Review
Anne Marie Stephen, Deborah Weinswig, digital health, digital technology, Fung Business Intelligence Centre, Jeffrey Woldt, KWOLIA, NACDS Total Store Expo
2015, Issue 09-14-2015, Issues, Opinion, Technology

The power of digital technology to shake up existing business models in health care and mass market retailing was a focal point for many of the executives in attendance at last month’s NACDS Total Store Expo in Denver. The changes that have occurred during the first few decades of the information age have been, in